Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001:1:5.
doi: 10.1186/1471-5945-1-5. Epub 2001 Aug 30.

Stratum corneum lipids liposomes for the topical delivery of 5-aminolevulinic acid in photodynamic therapy of skin cancer: preparation and in vitro permeation study

Affiliations

Stratum corneum lipids liposomes for the topical delivery of 5-aminolevulinic acid in photodynamic therapy of skin cancer: preparation and in vitro permeation study

M B Pierre et al. BMC Dermatol. 2001.

Abstract

Background: Photodynamic therapy (PDT) using 5-aminolevulinic acid (5-ALA) is a skin cancer therapy that still has limitations due to the low penetration of this drug into the skin. We have proposed in this work a delivery system for 5-ALA based on liposomes having lipid composition similar to the mammalian stratum corneum (SCLLs) in order to optimize its skin delivery in Photodynamic Therapy (PDT) of skin cancers.

Methods: SCLLs were obtained by reverse phase evaporation technique and size distribution of the vesicles was determinated by photon correlation spectroscopy. In vitro permeation profile was characterized using hairless mouse skin mounted in modified Franz diffusion cell.

Results: Size exclusion chromatography on gel filtration confirmed vesicle formation. SCLLs obtained by presented a degree of encapsulation of 5-ALA around 5.7%. A distribution of vesicle size centering at around 500 nm and 400 nm respectively for SCLLs and SCLLs containing 5-ALA was found. In vitro 5-ALA permeation study showed that SCLLs preparations presented higher skin retention significantly (p < 0.05) on the epidermis without SC + dermis, with a decreasing of skin permeation compared to aqueous solution.

Conclusions: The in vitro delivery performance provided by SCLLs lead to consider this systems adequate for the 5-ALA-PDT of skin cancer, since SCLLs have delivered 5-ALA to the target skin layers (viable epidermis + dermis) to be treated by topical PDT of skin cancer.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Elution profile of: (a) SCLLs and (b) 5-ALA solutions using size exclusion chromatography on a Sephadex G-75 column.
Figure 2
Figure 2
Amount of 5-ALA permeated (μg/cm2) through hairless mouse skin from the 5-ALA aqueous solution (black star) and SCLLs (square), as a function of time (hours).
Figure 3
Figure 3
Amount of 5-ALA (μg) permeated and retained in the SC and epidermis without SC + dermis after 36 hours of in vitro permeation study. Errors bars indicate standard deviation of the mean. Statistical significance indicated by one-tailed Student's t test: (*) P < 0.05) and (**) P < 0.001.

Similar articles

Cited by

References

    1. De Rosa FS, Bentley MVLB. Photodynamic therapy of skin cancers: sensitizers, clinical studies and future. Pharm Res. 2000;17:1447–1455. doi: 10.1023/A:1007612905378. - DOI - PubMed
    1. Fuchs J, Thiele J. The role of oxygen in cutaneous photodynamic therapy. Free Radical Biology & Medicine. 1998;24:835–847. doi: 10.1016/S0891-5849(97)00370-5. - DOI - PubMed
    1. Ackermann G, Abels C, Baumler W, Langer S, Landthaler M, Lang EW, Szeimies RM. Simulations on the selectivity of 5-aminolevulinic acid-induced fluorescence in vivo. J Photochem Photobiol B: Biol. 1998;47:121–128. doi: 10.1016/S1011-1344(98)00210-3. - DOI - PubMed
    1. Robinson DJ, Bruijn HS, Van Der Veen N, Stringer MR, Brown SB, Star WM. Fluorescence photobleaching of ALA-induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: the effect of light dose and irradiance and the resulting biological effect. Photochem Photobiol. 1998;67:140–149. - PubMed
    1. Morton AC, Whitehurst C, Moseley H, Mccoll JH, Moore JV, Mackie R. Comparision of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. Br J Dermatology. 1996;135:766–771. doi: 10.1046/j.1365-2133.1996.d01-1076.x. - DOI - PubMed

Publication types